Krempa C. David's most recent trade in Eton Pharmaceuticals Inc was a trade of 40,655 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 40,655 | 670,893 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 25,856 | 696,749 | - | - | Restricted Stock Units | |
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.62 per share. | 12 Jan 2026 | 1,942 | 630,238 (3%) | 0% | 15.6 | 30,334 | Common Stock |
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.00 per share. | 11 Dec 2025 | 6,264 | 632,180 (3%) | 0% | 17 | 106,488 | Common Stock |
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 5,300 | 638,468 | - | - | Restricted Stock Units | |
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.92 per share. | 12 Jun 2025 | 16,977 | 629,669 (3%) | 0% | 14.9 | 253,297 | Common Stock |
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.73 per share. | 12 Jun 2025 | 10,223 | 612,646 (3%) | 0% | 14.7 | 150,585 | Common Stock |
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.77 per share. | 12 Jun 2025 | 6,800 | 622,869 (3%) | 0% | 14.8 | 100,436 | Common Stock |
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 38,621 | 38,621 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 25,876 | 25,876 | - | - | Restricted Stock Units | |
| Eton Pharma Inc | David C. Krempa | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 42,088 | 861,374 | - | - | Restricted Stock Units | |
| Eton Pharma Inc | Krempa C. David | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 144,677 | 813,430 | - | - | Stock Option (Right to buy) |